Skip to main content
Premium Trial:

Request an Annual Quote

Commugene to Distribute Qlucore's Software in South Korean Market

Premium

NEW YORK (GenomeWeb) – Qlucore has signed an agreement with Commugene that lets the latter distribute its Qlucore Omics Explorer software to clients in the South Korean biotechnology and pharmaceutical markets.

"We are delighted to be entering into this agreement with Commugene," Carl-Johan Ivarsson, Qlucore's president said in a statement. "We are confident that this cooperation will help researchers in South Korea to learn more about our software, and to achieve extraordinary results with their data analysis."

"The biotech and pharmaceutical sectors in South Korea are growing very quickly, which means that there is a strong demand for truly innovative solutions in these areas," Jeong-hun Kim, Commugene's director of marketing and sales, added "We have no doubt that Qlucore Omics Explorer will be very attractive to the scientific community in South Korea."

Financial and other terms of the agreement were not disclosed.

The Scan

Team Tracks Down Potential Blood Plasma Markers Linked to Heart Failure in Atrial Fibrillation Patients

Researchers in BMC Genomics found 10 differentially expressed proteins or metabolites that marked atrial fibrillation with heart failure cases.

Study Points to Synonymous Mutation Effects on E. Coli Enzyme Activity

Researchers in Nature Chemistry saw signs of enzyme activity shifts in the presence of synonymous mutations in a multiscale modeling analysis of three Escherichia coli genes.

Team Outlines Paternal Sample-Free Single-Gene Approach for Non-Invasive Prenatal Screening

With data for nearly 9,200 pregnant individuals, researchers in Genetics in Medicine demonstrate the feasibility of their carrier screening and reflex single-gene non-invasive prenatal screening approach.

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.